MarketInOut Stock Screener Log In | Sign Up

Anatara Lifesciences Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 14:34
Anatara Lifesciences Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization2.85 mln
Float314 mln
Earnings Date02/24/2027

Piotroski F-Score

4 / 9
Borderline

Relative Strength

13 / 100
Significantly lagging

Pre-Tax Margin

-789%
Severely loss-making

ROE

-118
Deeply negative

ROA

-84.97
Deeply negative

Business Description

Anatara Lifesciences is an Australian health company focused on developing treatments for gut-related conditions in both people and animals. Its main product targets chronic digestive disorders such as irritable bowel syndrome, while another addresses diarrhea in young pigs. The company is also working on an oral treatment to help people manage their weight. Founded in 2010 and headquartered in Adelaide, Anatara builds its products on scientific evidence.

Key Fundamentals

EPS-0.00
ROE-118
RPS0.00
ROIC-236
ROA-84.97
Interest Cover-409
EBITDA, mln-1.25
EV / EBITDA-1.91
EV / EBIT-1.90
Revenue, mln0.32
EV / Revenue7.45

Quote Details

Last 0.008
Change 0 (0%)
Open 0.008
Volume 2,713,425
Turnover 21,707
Average Volume 284,141

Financial Ratios

Pre-Tax Profit Margin-789
Leverage Ratio1.15
Current Ratio7.58
Price / Book4.50
Price / Sales20.21

Financial Strength

Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.11% 8 / 100   
1 Month -20% 16 / 100   
2 Months -20% 22 / 100   
6 Months -42.86% 14 / 100   
1 Year 14.29% 81 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog